Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer

NCT00616967 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: carboplatin
DRUG: paclitaxel albumin-stabilized nanoparticle formulation
DRUG: vorinostat
OTHER: placebo

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]